Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
10,001 - 25,000 - Monthly Reach
Unique listeners across all episodes (30 days)
25,001 - 75,000 - Active Followers
Loyal subscribers who consistently listen
5,001 - 15,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
ICT Ep 2.18 What Recruitment Is Missing: Time, Trust, and a Cup of Tea
Apr 29, 2026
13m 44s
ICT Ep 2.17 Borrowing the F1 Playbook: What Formula One Gets Right That Clinical Trials Don't
Apr 16, 2026
14m 26s
ICT Ep. 2.16 Leading Teams That Take Risks and Deliver Results With Frank Watanabe (3/3)
Apr 13, 2026
13m 15s
ICT Ep. 2.15 Innovation, Risk and Building Great Teams With Frank Watanabe (2/3)
Apr 9, 2026
10m 36s
ICT Ep. 2.14 From Navy Officer to CEO: The DNA of Leadership with Frank Watanabe (1/3)
Apr 7, 2026
14m 45s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 4/29/26 | ICT Ep 2.18 What Recruitment Is Missing: Time, Trust, and a Cup of Tea | What does it actually mean to put the patient first? In this episode, Liam and Ted explore the role of empathy and human connection in clinical trials. From rushed pre-screening calls to a powerful story of pausing a consent conversation just to connect, they highlight how small moments build lasting trust. They also discuss why trust is rarely factored into budgets, despite being critical to recruitment, retention, and patient experience. A thoughtful conversation on why clinical research... | 13m 44s | ||||||
| 4/16/26 | ICT Ep 2.17 Borrowing the F1 Playbook: What Formula One Gets Right That Clinical Trials Don't | What makes a truly high-performing team? Inspired by the precision of Formula One pit crews, where the difference between winning and losing is measured in milliseconds, Ted and Liam explore what clinical trial teams can learn from elite performance environments. Ted outlines six principles that drive high-performing teams: clear objectives, defined roles, mapped processes, and a culture of continuous improvement. Liam draws on his experience in professional sport to reflect on why teams tha... | 14m 26s | ||||||
| 4/13/26 | ICT Ep. 2.16 Leading Teams That Take Risks and Deliver Results With Frank Watanabe (3/3) | In Part 3 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics discussing work-life balance, building social capital, and management vs. leadership. The conversation explores leadership at a practical level, from building trust across remote teams to creating flexibility that allows individuals to balance work and life in a way that works for them. Finally, he outlines his vision for Arcutis and what “meaningful innovation” really means focusing o... | 13m 15s | ||||||
| 4/9/26 | ICT Ep. 2.15 Innovation, Risk and Building Great Teams With Frank Watanabe (2/3) | In Part 2 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics, focusing on what it takes to hire and build high-performing teams in high-risk environments. Frank shares how he approaches hiring beyond technical skills placing strong emphasis on cultural fit, risk tolerance, and the ability to innovate. The discussion also explores how to create a culture where people feel comfortable taking risks and learning from failure. From encour... | 10m 36s | ||||||
| 4/7/26 | ICT Ep. 2.14 From Navy Officer to CEO: The DNA of Leadership with Frank Watanabe (1/3) | In this episode, Liam and Ted sit down with Frank Watanabe, President and CEO of Arcutis Biotherapeutics, to explore his journey from a Navy officer to a biotech executive and the leadership principles established along the way. Frank shares how his early experiences in the military and his transition into pharma and biotech influenced his approach to leadership, highlighting a key idea that defines his philosophy: leadership isn’t about authority, it’s about earning trust and loyalty... | 14m 45s | ||||||
| 4/1/26 | ICT Ep 2.13: The Hidden Complexity of Trial Feasibility | A patient in a database is not a patient in a trial. So why do we keep treating feasibility like a headcount? Fresh from a week deep in feasibility work, Liam introduces four characters who show up and cause chaos in almost every feasibility process. There's Spreadsheet Larry, who confuses a number with a truth. The EMR Oracle, who offers psychological safety dressed up as data. Prevalence Pete, who chases the sexiest percentage instead of the biggest addressable population. And... | 20m 49s | ||||||
| 3/18/26 | ICT Ep: 2.12: Dropping the Baton: Why Clinical Trial Handoffs Keep Failing | In elite sports, races are often won or lost in the transition, and Liam and Ted argue that the same is true in clinical trials. Drawing on the precision of Olympic relay racing, they make the case that the handoff points between sponsors, CROs, and sites are where trials quietly succeed or silently fall apart. From recruitment referrals that never get followed up, to sites given the green light before they're actually ready, the gaps are rarely dramatic, but the cost adds up. The culprit, m... | 13m 51s | ||||||
| 3/11/26 | ICT Ep 2.11: The Top 10 Signs Your Site Feasibility Process Is Off Track | Using a David Letterman-inspired “Top 10” format, the conversation highlights common feasibility pitfalls faced by sponsors, CROs, and clinical trial sites, including overly complex questionnaires, unrealistic enrollment expectations, delayed communication, and last-minute fire drills. The discussion goes beyond surface-level frustration to explore how sponsors and CROs can rethink clinical trial site feasibility by simplifying processes, questioning legacy requirements, and focusing o... | 10m 07s | ||||||
| 3/4/26 | ICT Ep 2.10 Where Clinical Trials Break Down, Even With Good Teams | Why do clinical trials struggle even when teams are experienced and well-intentioned? In this episode, Liam and Ted explore why these outcomes are rarely about individual performance and far more often about system-level misalignments. They unpack how incentives, information flow, and decision rights across sponsors, CROs, and sites shape behaviour and why execution tends to break down logically, not randomly. The discussion reframes “execution issues” as predictable outcomes of how trials ... | 18m 05s | ||||||
| 2/18/26 | ICT EP 2.9: Designing Eligibility Criteria That Work in the Real World | Eligibility criteria are meant to bring clarity to clinical trials, but in practice, they often do the opposite. In this episode of Innovating Clinical Trials, Liam and Ted unpack how poorly worded, ambiguous, or misaligned eligibility criteria quietly slow enrollment, frustrate sites, and introduce risk later in development. They explore: - Why small wording choices create big downstream problems - How “gray areas” force sites into interpretation rather than execution - The disconnect b... | 18m 14s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/11/26 | ICT EP 2.8: The Cost of Fragmented Enrollment Ownership And Why Leadership Must Step In | In this episode, Liam and Ted unpack why enrollment behaves more like an operating system rather than a standalone process. They explore the question of ownership, the role sponsors play through protocol design, and how operational practices, healthcare realities, and human behavior all influence who ultimately makes it into a study. The conversation moves through multiple lenses from eligibility criteria and healthcare documentation to behavioral science, site motivation, patient experience... | 17m 59s | ||||||
| 2/4/26 | ICT EP 2.7: Rethinking How Sponsors Build Site Relationships | In this episode of Innovating Clinical Trials, Liam and Ted explore why building strong relationships with clinical trial sites requires more than dedicated relationship teams, it requires fixing problems at their source. They discuss how many site challenges stem from outdated processes, one-sided agreements, and preventable operational friction that relationship teams are left to manage after the fact. Using real-world examples from confidentiality agreements to lab and portal issues, the ... | 12m 31s | ||||||
| 1/28/26 | ICT EP 2.6: What Shapes the Trajectory of a Clinical Trial | In this episode of Innovating Clinical Trials, Liam and Ted explore what determines the trajectory of a clinical trial and why success often depends on preparation, collaboration, and the ability to adapt when things don’t go as planned. They discuss how factors outside a site’s control, such as vendor selection and monitoring approaches, can significantly influence trial momentum. Through real-world examples, the conversation highlights how thoughtful planning, supportive site interactions,... | 15m 42s | ||||||
| 1/21/26 | ICT EP 2.5: Why Enrollment Is Slow and the Questions We’re Not Asking | In this episode of Innovating Clinical Trials, Liam and Ted challenge a familiar question in clinical research: “How do we increase enrollment?” Instead, they argue that progress starts by asking a better one- “What makes enrollment challenging in the first place?” They explore how study design, existing therapies, operational factors, and most importantly, the lived experience of participants and their families all shape recruitment outcomes. Ted shares a practical framework for slowing dow... | 14m 53s | ||||||
| 1/14/26 | ICT Ep 2.4: The Impact of Getting Site and Patient Engagement Right | In this episode of Innovating Clinical Trials, Liam and Ted explore why clinical research is, at its core, a people-driven business. Drawing on real-world experiences from both patient and site perspectives, they discuss how trust, communication, and human connection directly influence recruitment, retention, and study success. From participant consent conversations to site selection and prioritization, the discussion highlights how “soft skills” often have a measurable impact on trial perfo... | 15m 14s | ||||||
| 11/28/25 | ICT Ep 2.3: The Cost of Sponsors’ Extra Requests and what Sites can do about it | Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom. In this episode, Liam and Ted reveal how minor, unexpected requests often snowball into a significant site burden. They dive into why scope creep occ... | 12m 51s | ||||||
| 11/27/25 | ICP Ep 2.2: Building Better Sponsor-Site Partnerships | Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom. In this episode, Liam and Ted explore what it truly means to be a sponsor of choice for clinical trial sites. They discuss how communication gaps bet... | 14m 27s | ||||||
| 11/25/25 | ICT Ep 2.1: How Sponsors Win by Checking In Early with Sites | Welcome to Innovating Clinical Trials, the podcast designed for clinical research professionals eager to deepen their understanding of clinical trials through concise, insightful segments. Join your hosts, Liam Eves and Ted Trafford, as they uncover the core issues in clinical research, reflect on the industry, and challenge conventional wisdom. Season 2 kicks off with Liam and Ted exploring what it means to be a “Sponsor of Choice.” Through thoughtful analogies and real-world insights. They ... | 12m 19s | ||||||
| 4/16/25 | ICT Ep29: Feasibility is Broken: Maya Zlatanova on Redesigning Feasibility | Welcome to Innovating Clinical Trials, the podcast where Liam and Ted explore the evolving landscape of clinical research and challenge the assumptions holding it back. In this episode, we sit down with Maya Zlatanova — CEO of TrialHub and FindMeCure, and host of Trials with Maya Z — for a no-nonsense look at one of the most misunderstood concepts in research: feasibility. Episode Overview: Maya takes us deep into the hidden layers of clinical trial feasibility, arguing that what most of the ... | 46m 14s | ||||||
| 3/3/25 | ICT Ep28: Recruitment Solutions with Jill Pellegrino | Welcome to the Innovating Clinical Trials podcast, where we explore the evolving landscape of clinical research. In this episode, hosts Liam Eves and Ted Trafford sit down with Jill Pellegrino, CEO of AutoCruitment, to explore the future of patient enrollment in clinical trials. With a background spanning leadership roles at CVS Health, PPD, and Accelerated Enrollment Solutions, Jill brings deep expertise in leveraging technology and data-driven strategies to improve recruitment efficiency. J... | 30m 18s | ||||||
| 2/20/25 | ICT Ep27: Expanding the Scope of Feasibility in Clinical Trials with Nick Palumbo (Part 3 of 3) | Welcome to the Innovating Clinical Trials podcast, where we explore the evolving landscape of clinical research. In this episode, hosts Liam Eves and Ted Trafford continue the conversation with clinical trial feasibility expert Nick Palumbo to examine why feasibility is much more than just site selection—and how rethinking the process can drive better enrollment and study success. Nick shares his insights on the broader role of feasibility, from protocol optimization to enrollment modeling, a... | 11m 29s | ||||||
| 2/20/25 | ICT Ep26: Balancing Data, Technology, and Human Expertise in Feasibility with Nick Palumbo (Part 2 of 3) | Welcome to the Innovating Clinical Trials podcast, where we explore the evolving landscape of clinical research. In this episode, hosts Liam Eves and Ted Trafford continue the conversation with clinical research expert Nick Palumbo, diving into the role of data, digital tools, and human expertise in clinical trial feasibility and patient recruitment. Nick shares his insights on the increasing reliance on data-driven approaches for enrollment forecasting and site selection, while also highligh... | 11m 38s | ||||||
| 2/20/25 | ICT Ep25: A deep dive into Feasibility with Nick Palumbo (Part 1 of 3) | Welcome to the Innovating Clinical Trials podcast, where we explore the evolving landscape of clinical research. In this episode, hosts Liam Eves and Ted Trafford sit down with clinical research expert Nick Palumbo to unpack the challenges and opportunities in the feasibility process. Nick brings over two decades of experience in clinical operations, offering deep insights into sponsors, CROs, and research sites when it comes to feasibility assessments. From the burden of feasibility question... | 20m 35s | ||||||
| 12/13/24 | ICT Ep24: Q3 Results with Joel White (Part 3) | Innovating Clinical Trials Podcast Series: Part 3 - Opportunities in Patient Recruitment and Industry Transformation Welcome to Innovating Clinical Trials podcast, where we explore the cutting-edge shifts in clinical research. In this episode, hosts Liam Eves and Ted Trafford wrap up the series with industry analyst Joel White, diving into opportunities in patient recruitment, site network growth, and the evolving role of technology. Joel shares his insights on breaking down the root causes o... | 10m 04s | ||||||
| 12/13/24 | ICT Ep23: Q3 Results with Joel White (Part 2) | Innovating Clinical Trials Podcast Series: Part 2 - Pricing Strategies and Emerging Dynamics Welcome to Innovating Clinical Trials podcast, where we continue to explore the rapidly evolving landscape of clinical research. In part 2, hosts Liam Eves and Ted Trafford are joined once again by industry analyst Joel White to dive into the complexities of pricing strategies and the shifting dynamics in the CRO and biotech sectors. This episode unpacks the implications of pricing pressures, the role... | 17m 49s | ||||||
Showing 25 of 47
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
6 placements across 6 markets.
Chart Positions
6 placements across 6 markets.